The Effect of Oxidative Phosphorylation on Cancer Drug Resistance

Area of Science:

• Metabolic reprogramming in cancer
• Mitochondrial function and cancer
• Tumor microenvironment (TME) interactions

Background:

• Oxidative phosphorylation (OXPHOS) is increasingly recognized as a key factor in cancer drug resistance.
• OXPHOS inhibitors show promise in enhancing anticancer therapy responses across various cancer types.
• The role of OXPHOS in cancer is complex, influenced by different cell types within the tumor microenvironment (TME).

Purpose of the Study:

• To review recent research on the dual role of OXPHOS in cancer drug resistance and progression.
• To elucidate the mechanisms by which cancer cells reprogram metabolism to promote OXPHOS.
• To highlight OXPHOS as a potential therapeutic target for overcoming cancer drug resistance.

Main Methods:

• Review of current scientific literature on OXPHOS, cancer metabolism, and drug resistance.
• Analysis of signaling pathways involved in metabolic reprogramming in cancer cells.
• Examination of the impact of OXPHOS on cancer stem cells (CSCs) and tumor-infiltrating immune cells.

Main Results:

• Cancer cells universally upregulate OXPHOS, contributing to resistance against anticancer drugs.
• Cancer stem cells (CSCs), characterized by high OXPHOS, are selectively vulnerable to OXPHOS inhibitors.
• Mitochondrial OXPHOS is downregulated in tumor-infiltrating T cells, impairing anti-tumor immunity.

Conclusions:

• OXPHOS plays a critical, dual role in cancer: promoting resistance in cancer cells while potentially hindering anti-tumor immunity.
• Targeting OXPHOS in cancer cells and CSCs offers a promising strategy to overcome drug resistance.
• Further research into metabolic reprogramming mechanisms is vital for identifying novel therapeutic targets.